Table 2.

Demographic and outcomes characteristics of the study cohort (non-transplanted) and transplanted patients

	Study Cohort (n = 522)		Transplanted Patients (n = 262)
	N	%	N	%
Sex
Male	273	52.3	149	56.9
Female	249	47.7	113	43.1
Ethnicity
Not Hispanic or Latino	421	80.7	205	78.2
Hispanic or Latino	101	19.3	57	21.8
Race
Caucasian	355	68.9	187	71.4
Non-white	167	31.1	57	21.8
Age (years)
Mean	2.7		5.5
Range	0.0 – 17.9		0.0–17.9
<1 year	192	36.8	48	18.3
1–2.9 years	78	14.9	42	16.0
3–9.9 years	120	23.0	95	36.3
10–17.9 years	132	25.3	77	29.4
Final Diagnosis
Indeterminate	225	43.1	179	68.3
Budd-Chiari	2	0.4	1	0.4
Hemophagocytic Syndrome	17	3.3	2	0.8
Ischemia	29	5.6	1	0.4
Neonatal Iron Storage	17	3.3	5	1.9
Veno-occlusive disease	10	1.9	1	0.4
Wilson’s disease	11	2.1	23	8.8
Metabolic disorder	49	9.4	8	3.1
Viral hepatitis	55	10.5	12	4.6
Autoimmune hepatitis	45	8.6	15	5.7
Drug-induced	19	3.6	6	2.3
Mushroom toxicity	2	0.4	2	0.8
Other	25	4.8	4	1.5
Outcomes
21-day mortality	110	21.1
Recovery	412	78.9